Mechanical thrombectomy for the treatment of acute ischemic stroke

References

• Di Carlo A. Human and economic burden of stroke. Age Ageing38, 4–5 (2009).
   PubMed Web of Science ®Google Scholar
• Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modelling. Lancet Neurol.8, 345–354 (2009).
   PubMed Web of Science ®Google Scholar
• Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group. N. Engl. J. Med.333, 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The proact II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA282, 2003–2011 (1999).
   PubMed Web of Science ®Google Scholar
• Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke36, 1432–1438 (2005).
   PubMed Web of Science ®Google Scholar
• Broderick JP. Endovascular therapy for acute ischemic stroke. Stroke40, S103–S106 (2009).
   PubMed Web of Science ®Google Scholar
• Baird TA, Muir KW, Bone I. Basilar artery occlusion. Neurocrit. Care1, 319–329 (2004).
   PubMed Web of Science ®Google Scholar
• Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial doppler predicts the response to intravenous thrombolysis for stroke. Stroke38, 948–954 (2007).
   PubMed Web of Science ®Google Scholar
• Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke37, 922–928 (2006).
   PubMed Web of Science ®Google Scholar
• Smith WS, Tsao JW, Billings ME et al. Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia. Neurocrit. Care4, 14–17 (2006).
   PubMed Web of Science ®Google Scholar
• Zangerle A, Kiechl S, Spiegel M et al. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology68, 39–44 (2007).
   PubMed Web of Science ®Google Scholar
• Wunderlich MT, Goertler M, Postert T et al. Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology68, 1364–1368 (2007).
   PubMed Web of Science ®Google Scholar
• Brekenfeld C, Remonda L, Nedeltchev K et al. Endovascular neuroradiological treatment of acute ischemic stroke: techniques and results in 350 patients. Neurol Res.27(Suppl. 1), S29–S35 (2005).
   PubMed Web of Science ®Google Scholar
• Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke38, 967–973 (2007).
   PubMed Web of Science ®Google Scholar
• Tan IY, Demchuk AM, Hopyan J et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am. J. Neuroradiol.30, 525–531 (2009).
   PubMed Web of Science ®Google Scholar
• Alexandrov AV, Molina CA, Grotta JC et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N. Engl. J. Med.351, 2170–2178 (2004).
   PubMed Web of Science ®Google Scholar
• Ribo M, Alvarez-Sabin J, Montaner J et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke37, 1000–1004 (2006).
   PubMed Web of Science ®Google Scholar
• Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation103, 2897–2902 (2001).
   PubMed Web of Science ®Google Scholar
• Arnold M, Nedeltchev K, Remonda L et al. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J. Neurol. Neurosurg. Psychiatry76, 1373–1376 (2005).
   PubMed Web of Science ®Google Scholar
• Zaidat OO, Suarez JI, Sunshine JL et al. Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am. J. Neuroradiol.26, 880–884 (2005).
   PubMed Web of Science ®Google Scholar
• Stead LG, Gilmore RM, Bellolio MF, Rabinstein AA, Decker WW. Percutaneous clot removal devices in acute ischemic stroke: a systematic review and meta-analysis. Arch. Neurol.65, 1024–1030 (2008).
   PubMedGoogle Scholar
• Soares BP, Chien JD, Wintermark M. MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse! Stroke40, S24–S27 (2009).
   PubMed Web of Science ®Google Scholar
• Liebeskind DS. Reperfusion for acute ischemic stroke: arterial revascularization and collateral therapeutics. Curr. Opin. Neurol.23(1), 36–45 (2010).
   PubMed Web of Science ®Google Scholar
• Soares BP, Tong E, Hom J et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization. A proof of concept using CT in acute ischemic stroke patients. Stroke41(1), E34–E40 (2010).
   PubMed Web of Science ®Google Scholar
• De Silva DA, Fink JN, Christensen S et al. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke40, 2872–2874 (2009).
   PubMed Web of Science ®Google Scholar
• Ehlers L, Andersen G, Clausen LB, Bech M, Kjolby M. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke. Stroke38, 85–89 (2007).
   PubMed Web of Science ®Google Scholar
• Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA stroke trial. Stroke28, 2119–2125 (1997).
   PubMed Web of Science ®Google Scholar
• Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of atlantis, ecass, and ninds rt-PA stroke trials. Lancet363, 768–774 (2004).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med.359, 1317–1329 (2008).
   PubMed Web of Science ®Google Scholar
• Bluhmki E, Chamorro A, Davalos A et al. Stroke treatment with alteplase given 3.0–4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol.8, 1095–1102 (2009).
   PubMed Web of Science ®Google Scholar
• Lansberg MG, Bluhmki E, Thijs VN. Efficacy and safety of tissue plasminogen activator 3- to 4.5-hours after acute ischemic stroke. A metaanalysis. Stroke40(7), 2438–2441 (2010).
   Web of Science ®Google Scholar
• Clark WM, Madden KP. Keep the three hour tPA window: the lost study of atlantis. J. Stroke Cerebrovasc. Dis.18, 78–79 (2009).
   PubMed Web of Science ®Google Scholar
• Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator. A science advisory from the American Heart Association/American Stroke Association. Stroke40(8), 2945–2948 (2009).
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Yoo AJ, Buonanno FS, Hirsch JA. Endovascular approaches to acute stroke, part 2: a comprehensive review of studies and trials. AJNR Am. J. Neuroradiol.30, 859–875 (2009).
   PubMed Web of Science ®Google Scholar
• Ogawa A, Mori E, Minematsu K et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke38, 2633–2639 (2007).
   PubMed Web of Science ®Google Scholar
• Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke39, 1205–1212 (2008).
   PubMed Web of Science ®Google Scholar
• Bose A, Henkes H, Alfke K et al. The penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am. J. Neuroradiol.29, 1409–1413 (2008).
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation115, E478–E534 (2007).
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism. Stroke29, 4–11 (1998).
   PubMed Web of Science ®Google Scholar
• Saver JL. Intra-arterial fibrinolysis for acute ischemic stroke: the message of MELT. Stroke38, 2627–2628 (2007).
   PubMed Web of Science ®Google Scholar
• Josephson SA, Saver JL, Smith WS. Comparison of mechanical embolectomy and intraarterial thrombolysis in acute ischemic stroke within the MCA: MERCI and multi MERCI compared to PROACT II. Neurocrit. Care10, 43–49 (2009).
   PubMed Web of Science ®Google Scholar
• The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke40, 2761–2768 (2009).
   PubMed Web of Science ®Google Scholar
• Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke28, 2109–2118 (1997).
   PubMed Web of Science ®Google Scholar
• Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA282, 2019–2026 (1999).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet352, 1245–1251 (1998).
   PubMed Web of Science ®Google Scholar
• Gobin YP, Starkman S, Duckwiler GR et al. MERCI 1: a Phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke35, 2848–2854 (2004).
   PubMed Web of Science ®Google Scholar
• Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi mechanical embolus removal in cerebral ischemia (MERCI) trial, part I. AJNR Am. J. Neuroradiol.27, 1177–1182 (2006).
   PubMed Web of Science ®Google Scholar
• Lansberg MG, Thijs VN, Bammer R et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke38, 2275–2278 (2007).
   PubMed Web of Science ®Google Scholar
• Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis.24, 1–10 (2007).
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Smith WS. Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and multi MERCI trials. Stroke40, 516–522 (2009).
   PubMed Web of Science ®Google Scholar
• Smith WS, Lev MH, English JD et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke40, 3834–3840 (2009).
   PubMed Web of Science ®Google Scholar
• Meyers PM, Schumacher HC, Higashida RT et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation119, 2235–2249 (2009).
   PubMed Web of Science ®Google Scholar
• Mahon BR, Nesbit GM, Barnwell SL et al. North American clinical experience with the ekos microlysus infusion catheter for the treatment of embolic stroke. AJNR Am. J. Neuroradiol.24, 534–538 (2003).
   PubMed Web of Science ®Google Scholar
• IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke38, 2127–2135 (2007).
   PubMed Web of Science ®Google Scholar
• Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke35, 904–911 (2004).
   PubMed Web of Science ®Google Scholar
• Lum C, Stys PK, Hogan MJ, Nguyen TB, Srinivasan A, Goyal M. Acute anterior circulation stroke: recanalization using clot angioplasty. Can. J. Neurol. Sci.33, 217–222 (2006).
   PubMed Web of Science ®Google Scholar
• Choi JW, Kim JK, Choi BS et al. Adjuvant revascularization of intracranial artery occlusion with angioplasty and/or stenting. Neuroradiology51, 33–43 (2009).
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Schwamm LH, Buonanno FS et al. Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions. Neuroradiology50, 331–340 (2008).
   PubMed Web of Science ®Google Scholar
• Kelly ME, Furlan AJ, Fiorella D. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke39, 1770–1773 (2008).
   PubMed Web of Science ®Google Scholar
• Levy EI, Mehta R, Gupta R et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am. J. Neuroradiol.28, 816–822 (2007).
   PubMed Web of Science ®Google Scholar
• Brekenfeld C, Schroth G, Mattle HP et al. Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke40, 847–852 (2009).
   PubMed Web of Science ®Google Scholar
• Lansberg MG, Fields JD, Albers GW, Jayaraman MV, Do HM, Marks MP. Mechanical thrombectomy following intravenous thrombolysis in the treatment of acute stroke. Arch. Neurol.62, 1763–1765 (2005).
   PubMedGoogle Scholar
• Burns TC, Rodriguez GJ, Patel S et al. Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case–control study. AJNR Am. J. Neuroradiol.29, 1918–1924 (2008).
   PubMed Web of Science ®Google Scholar
• Sekoranja L, Loulidi J, Yilmaz H et al. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography-guided pilot study. Stroke37, 1805–1809 (2006).
   PubMed Web of Science ®Google Scholar
• Arnold M, Kappeler L, Nedeltchev K et al. Recanalization and outcome after intra-arterial thrombolysis in middle cerebral artery and internal carotid artery occlusion: does sex matter? Stroke38, 1281–1285 (2007).
   PubMed Web of Science ®Google Scholar
• Lin R, Vora N, Zaidi S et al. Mechanical approaches combined with intra-arterial pharmacological therapy are associated with higher recanalization rates than either intervention alone in revascularization of acute carotid terminus occlusion. Stroke40, 2092–2097 (2009).
   PubMed Web of Science ®Google Scholar
• Noser EA, Shaltoni HM, Hall CE et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke36, 292–296 (2005).
   PubMed Web of Science ®Google Scholar
• Shaltoni HM, Albright KC, Gonzales NR et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke38, 80–84 (2007).
   PubMed Web of Science ®Google Scholar
• Gupta R, Vora NA, Horowitz MB et al. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke37, 986–990 (2006).
   PubMed Web of Science ®Google Scholar
• Vora NA, Gupta R, Thomas AJ et al. Factors predicting hemorrhagic complications after multimodal reperfusion therapy for acute ischemic stroke. AJNR Am. J. Neuroradiol.28, 1391–1394 (2007).
   PubMed Web of Science ®Google Scholar
• Raphaeli G, Eichel R, Ben-Hur T, Leker RR, Cohen JE. Multimodal reperfusion therapy in patients with acute basilar artery occlusion. Neurosurgery65, 548–552; discussion 552–553 (2009).
   PubMed Web of Science ®Google Scholar
• Leker RR, Eichel R, Arkadir D et al. Multi-modal reperfusion therapy for patients with acute anterior circulation stroke in israel. Stroke40, 3627–3630 (2009).
   PubMed Web of Science ®Google Scholar
• Nedeltchev K, Arnold M, Brekenfeld C et al. Pre- and in-hospital delays from stroke onset to intra-arterial thrombolysis. Stroke34, 1230–1234 (2003).
   PubMed Web of Science ®Google Scholar
• Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet369, 275–282 (2007).
   PubMed Web of Science ®Google Scholar
• Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology73, 1066–1072 (2009).
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the mechanical embolus removal in cerebral ischemia (MERCI) and Multi MERCI trials. Stroke40, 3777–3783 (2009).
   PubMed Web of Science ®Google Scholar
• Albers GW, Thijs VN, Wechsler L et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (defuse) study. Ann Neurol.60, 508–517 (2006).
   PubMed Web of Science ®Google Scholar
• Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (epithet): a placebo-controlled randomised trial. Lancet Neurol.7, 299–309 (2008).
   PubMed Web of Science ®Google Scholar
• Becker KJ, Brott TG. Approval of the MERCI clot retriever: a critical view. Stroke36, 400–403 (2005).
   PubMed Web of Science ®Google Scholar
• Wasiewski WW, Johnston KC. Clinical trials, devices, unproven treatments, and clinical equipoise. Stroke40. E441–E442 (2009).
   Google Scholar
• Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI part I trials. Stroke38, 1274–1280 (2007).
   PubMed Web of Science ®Google Scholar
• Khatri P, Hill MD, Palesch YY et al. Methodology of the interventional management of stroke III trial. Int. J. Stroke3, 130–137 (2008).
   PubMed Web of Science ®Google Scholar